Xilis
PrivateLast Round
Series A
Extension
Jul 13, 2022
Total Funding Raised
$28.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Xilis operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Series A Extension round in July 2022.
Xilis is a biotechnology company that develops MicroOrganoSphere (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xilis Comparables
Compare Xilis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AimingMed | 83% | |
| Keliomics | 81% | |
| Shanghai Wanheyuan Biotechnology Co., Ltd. | 79% |
For institutional investors. Book with your work email.
Xilis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 13, 2022 | ||||
| Debt | Jul 8, 2021 | ||||
| Seed | May 21, 2020 | ||||
| Seed | Dec 19, 2019 |
For institutional investors. Book with your work email.
Xilis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Debt, Series A Extension |
| GV | Debt, Series A Extension |
| The Duke Endowment | Debt |
| Alix Ventures | Debt, Series A Extension |
| Catalio Capital Management | Debt, Series A Extension |
| Two Sigma Ventures | Debt, Series A Extension |
| Pear VC | Series A Extension, Seed, Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 45% MoM.
- Jun 18, 2026
Monthly visitors grew 480% MoM to 2.2K.
For institutional investors. Book with your work email.
Xilis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xilis's valuation, stock price, and market status.
Is Xilis a public or private company?
Xilis is a private company.
What is the current stock price of Xilis?
Xilis is a private company, so its shares have no public market price. Caplight tracks Xilis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xilis worth (valuation)?
Valuation information for Xilis is not publicly available.
Can I buy Xilis stock?
Xilis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xilis's last funding round?
Xilis's most recent funding round was Series A Extension on July 13, 2022.
Who are the main investors in Xilis?
Key investors in Xilis include Mubadala Capital, FPV Ventures, Felicis Ventures.
Will Xilis IPO soon?
No public IPO plans have been announced for Xilis.
How can I track Xilis secondary market activity?
Caplight tracks bids, offers, and trades in Xilis's shares on secondary markets.